Published in TB and Outbreaks Week, November 22nd, 2005
In addition, the vaccine has shown a good safety and immunogenicity profile in early stage clinical trials conducted by GSK Biologicals. TB causes 2 million deaths a year, and is a leading cause of death among people with AIDS in the developing world.
The announcement was made during the World Conference on Lung Health in Paris, France.
Over the coming months,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week